Tenon Medical

TNON · NASDAQ

$2.51+$0.06 (+2.45%)TodayMarket closed ·
Prev close $2.45

About TNON

Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company is headquartered in Los Gatos, California and currently employs 26 full-time employees. The company went IPO on 2022-04-27. The firm has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Its trademarks include Catamaran, PiSIF, CAT PiSIF, ETAD, CAT SIJ Fusion System, SImmetry, MAINSAIL, SImmetry+, Catamaran Transfixation Fusion Device, Catamaran Transfixation Fusion System, and others. The Catamaran SI Joint Fusion System offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant.

Employees
26
Headquarters
Los Gatos, California
Listed
Apr 27, 2022
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Tenon Medical executives
NameTitleSince
Richard Ferrari——
Steven Foster——
Kevin Williamson——
Richard Ginn——
Stephen Hochschuler——
Ivan Howard——
Kristine Jacques——
Robert Weigle——
Shannon Devine—2022

Similar companies

Companies in the same industry as Tenon Medical

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.